DrugDashboards

Lidocaine Hydrochloride

Lidocaine Hydrochloride · LIDOCAINE HYDROCHLORIDE 40 mg/mL · Solution · Topical · PAI Holdings, LLC dba PAI Pharma

NDC 00121-0972-51 · 1 BOTTLE, GLASS in 1 CARTON / 50 mL in 1 BOTTLE, GLASS · ANDA · View full market →

The short version

31 companies supply this market — deep enough that no single failure threatens the supply. The price is down 27% over the past year, to $0.2080 per mL. It is in shortage right now — FDA lists the reason as “demand increase for the drug”. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00054-3505-47) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.4563per unit
middle half $0.3849–$0.6551 · 3,572 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.4563
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
65%of plans cover it
tier 3 · prior auth 39% · step therapy 0% · qty limit 54%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

$0$0.2$0.4$0.6Oct 2023Sep 2026$0.208
34 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$19.99
Reported to Texas DSHS · 2026 annual filing · PAI Holdings LLC dba Pharmaceutical Associates, Inc. / PAI Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2026 YTD · Q1)ⓘ

$207
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

31● Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • related presentation in shortage+15
  • Class I/II recall on same molecule/form in past 12 months+8
  • price down 25% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for lidocaine hydrochloride (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · 2 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA204494
TE code
AT
Approval date
Mar 12, 2014
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)Jul 14, 2018
    Demand increase for the drug
    month 98 — 8× the typical 12-month other shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lidocaine Hydrochloride (Solution)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackLIDOCAINE HYDROCHLORIDE ANHYDROUS 40 mg/mLJul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Chartwell RX, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
Huons Co., Ltd.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
NuCare Pharmaceuticals,Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Preferred Pharmaceuticals Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Remedyrepack Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Advagen Pharma LtdLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
American Health PackagingLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Atlantic Biologicals Corp.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Atlantic Biologicals Corp.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Chartwell Governmental & Specialty RX, LLC.LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.LIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.LIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Lannett Company, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 40 mg/mLJul 15, 2026Sep 2, 2026
Major PharmaceuticalsLIDOCAINE HYDROCHLORIDE 20 mg/mLAug 26, 2026Sep 2, 2026
Marlex Pharmaceuticals, Inc.LIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
McKesson Corporation dba SKY PackagingLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
McKesson Corporation dba SKY PackagingLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Novagenix Labs LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Novagenix Labs LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Novitium Pharma LLCLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Precision Dose, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Prime Commerce, LLCLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.LIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
The J. Molner Company LLCLIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Xttrium Laboratories, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Xttrium Laboratories, Inc.LIDOCAINE HYDROCHLORIDE 40 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Aug 31, 2026
Brookfield Pharmaceuticals, LLC.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Aug 31, 2026
PAI Holdings, LLC dba PAI PharmaLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Aug 31, 2026
Brookfield Pharmaceuticals, LLC.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Aug 28, 2026
Huons Co., Ltd.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Aug 28, 2026
Skins Sexual Health LimitedLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine Hydrochloride — NDC 00121-0972-51," retrieved September 3, 2026, https://drugdashboards.com/drug/00121097251.

Free to cite with attribution — see how the data is put together.